Therapy of allergic rhinitis;Therapie der neurodermitis (atopische dermatitis)

Therapeutische Umschau

Volumn 58, Issue 5, 2001, Pages 304-314

  Senti, G ^b   Wuthrich B ^b   Bircher, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALLERGEN; AZELASTINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; EYE DROPS; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; IPRATROPIUM BROMIDE; LEVOCABASTINE; LORATADINE; MIZOLASTINE; MOMETASONE FUROATE; N ACETYLASPARTYLGLUTAMIC ACID; NEDOCROMIL; NEDOCROMIL SODIUM; OXYMETAZOLINE; RHINOVENT; TIXOCORTOL PIVALATE; TRIAMCINOLONE ACETONIDE; TRIOFAN; XYLOMETAZOLINE; ALCLOMETASONE DIPROPIONATE; ALFACORTON; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CLOBETASONE; CLOBETASONE BUTYRATE; EMOLLIENT AGENT; FLUMETASONE; FLUMETASONE PIVALATE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; HEXACORTON; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACEPONATE; PREDNICARBATE; PREDNISOLONE; PREMANDOL; SANADERMIL;

ADRENAL INSUFFICIENCY; ALLERGIC RHINITIS; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; IMMUNOTHERAPY; NOSE DISEASE; NOSE POLYP; PREVALENCE; QUALITY OF LIFE; REVIEW; SINUSITIS; ATOPIC DERMATITIS; BACTERIAL INFECTION; MYCOSIS; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIMARY PREVENTION; RISK FACTOR; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VIRUS INFECTION;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ADULT; ANTI-ALLERGIC AGENTS; CHILD; COMBINED MODALITY THERAPY; HISTAMINE ANTAGONISTS; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; GLUCOCORTICOIDS; NEURODERMATITIS;

EID: 0035025794     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.58.5.304     Document Type: Article

References (8)

1. Wüthrich B, Schindler C, Leuenberger P, et al. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study) Swiss Study on Air pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 1995; 106: 1149-56.
2. International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Managment of Rhinitis. Allergy 1994; 49 Suppl 9: 5-34.
3. Heppt W. Allergologie. Springer, Berlin, Heidelberg, New York, 1998.
4. Mygind N, et al. Allergologie. Blackwell Wissenschafts-Verlag, Berlin, Wien, 1998.
5. Passalacqua G , Bachert C, Davies RJ, Durham SR, et al. Inhaled and nasal corticosteroids: safety aspects. Position paper. Allergy 2000; 55: 16-33.
6. Mygind N, Laursen LC, Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Review article. Allergy 2000; 55: 11-15.
7. Cauwenberge van P et al. Consensus statement on the treatment of allergic rhinitis. Position paper. Allergy 2000; 55: 116-34.
8. Malling HJ. The position of immunotherapy in the European Academy of Allergology and Clinical Immunology. J Investig Allergol Clin Immunol 1997; 356-7.